4.7 Article

Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke Japan Stroke Data Bank

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016

Valery L. Feigin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Neurosciences

Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5)

Takenori Yamaguchi et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)

Article Neurosciences

Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5)

Takenori Yamaguchi et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)

Review Clinical Neurology

Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials

Jie Yang et al.

DEVELOPMENTAL NEUROREHABILITATION (2015)

Review Clinical Neurology

Clinical Trials in Acute Ischemic Stroke

Kiyoshi Kikuchi et al.

CNS DRUGS (2014)

Article Medicine, General & Internal

Efficacy of the Free Radical Scavenger, Edaravone, for Motor Palsy of Acute Lacunar Infarction

Yasuyuki Ohta et al.

INTERNAL MEDICINE (2009)

Article Public, Environmental & Occupational Health

International experience in stroke registry - Japanese stroke databank

Shotai Kobayashi

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2006)

Article Medicine, General & Internal

Efficacy of edaravone in cardioembolic stroke

Yuichiro Inatomi et al.

INTERNAL MEDICINE (2006)

Article Clinical Neurology

Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion

K Toyoda et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)